ESR1 and carcinoma: Tumors in the adenoma and epithelioma groups, which showed high AR and ER expression in the previous 2021 study, were subject to a significantly greater and faster reduction in diameter over the course of treatment when receiving antihormonal therapy compared to tumors in the carcinoma group.